Does VORTIOXETINE HYDROBROMIDE Cause Therapy cessation? 45 Reports in FDA Database
Sharpen Your Memory & Focus Naturally
NeuroZoom — 35 clinically studied ingredients. No stimulants. Pure brain support.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Therapy cessation have been filed in association with VORTIOXETINE HYDROBROMIDE (Trintellix). This represents 0.3% of all adverse event reports for VORTIOXETINE HYDROBROMIDE.
45
Reports of Therapy cessation with VORTIOXETINE HYDROBROMIDE
0.3%
of all VORTIOXETINE HYDROBROMIDE reports
0
Deaths
3
Hospitalizations
How Dangerous Is Therapy cessation From VORTIOXETINE HYDROBROMIDE?
Of the 45 reports, 3 (6.7%) required hospitalization, and 3 (6.7%) were considered life-threatening.
Is Therapy cessation Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for VORTIOXETINE HYDROBROMIDE. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does VORTIOXETINE HYDROBROMIDE Cause?
Nausea (2,062)
Anxiety (861)
Vomiting (811)
Suicidal ideation (742)
Headache (738)
Fatigue (697)
Drug ineffective (693)
Pruritus (653)
Insomnia (636)
Feeling abnormal (620)
What Other Drugs Cause Therapy cessation?
DALFAMPRIDINE (4,580)
ETANERCEPT (2,031)
ADALIMUMAB (1,712)
ABIRATERONE (1,602)
VOXELOTOR (1,038)
CLOZAPINE (885)
LOMITAPIDE (828)
CAPECITABINE (746)
TREPROSTINIL (743)
ISOTRETINOIN (633)
Which VORTIOXETINE HYDROBROMIDE Alternatives Have Lower Therapy cessation Risk?
VORTIOXETINE HYDROBROMIDE vs VOSORITIDE
VORTIOXETINE HYDROBROMIDE vs VOTRIENT
VORTIOXETINE HYDROBROMIDE vs VOXELOTOR
VORTIOXETINE HYDROBROMIDE vs VUTRISIRAN
VORTIOXETINE HYDROBROMIDE vs VX-950